Sanofi-Aventis closes Chattem acquisition
11 March 2010
Simon Varcoe
simon.varcoe@informa.com
Sanofi-Aventis has completed its €1.9 billion acquisition of the OTC and branded consumer product company
Chattem.
Chattem's common stock ceased trading on Nasdaq after market close on March 10th and the company has become a wholly-owned subsidiary of the French pharma giant.
Sanofi-Aventis...
Please Login to read the full article.